DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
.....
The worldwide biologics market was 160 billion dollars in 2012. Half of this was from US sales..READ ALL AT
http://blog.bioinfomedical.com/2024-biosimilars-10-years-from-now/
ABOUT AUTHOR OF THE BLOGPOST
Dr. Rafael “Rafi” Boritzer
Global Biotech Marketer, Serial Entrepreneur, Academician, Chair of Bioinfomedical Ltd.
| Current |
|---|
Chairman of the Board of Directors
Bioinfomedical Ltd. / InfoMedical L.L.C.
Started and built entrepreneurial venture that began as a consulting firm and grew into a successful business engaged in the global transfer of medical/gerontological technologies and software, marketing of research cytokines, and strategic alliances with bio-similar producers. Fostered relationships in Hawaii, Central/Southeast Asia, Oceania, Central Europe, Middle East, and East Africa, to accelerate growth of the business and further its objectives. Created differentiation strategies designed to cope with competitive marketing pressures primarily in long-term healthcare, specialty medical institutions and pharmaceutical distributors in the U.S. and Southeast Asia.
ABOUT HIM BY HIM
Over the course of my 20+ year career as an interdisciplinary and multicultural university educator, social scientist, marketer, entrepreneur and administrator, I have directed organizations, programs and initiatives that promote academic excellence, improve student performance, and strengthen educational outcomes. I have taught at Professor levels in the disciplines of healthcare administration, healthcare management information systems, sociology, global marketing and more. I have a track record in leading and participating in accreditation requirements, and in driving the design and development of curriculum and course offerings, at both graduate and undergraduate levels. My international experience encompasses five continents and I have an in-depth understanding of geopolitical contexts of business and effects on global and local economy and education.
Complementing my teaching and administrative background is executive and research experience in healthcare, geriatrics, entrepreneurship, and marketing, including the conceptualization, startup, and growth of a successful firm engaged in the global transfer of medical/gerontological technologies and software, marketing of research cytokines, and strategic alliances. InfoMedical Biotechnology (www.bioinfomedical.com) satisfies customers’ demand for high quality cytokine products. The use of medical diagnostics is growing in importance, as bigger proportion of the world’s population age and the cost of healthcare continues to rise. The company provides scientists with tools to investigate the genetic and molecular basis for human development and disease; knowledge that is applied in development, discovery and manufacture of new drugs.
Specialties: Education Program Development; Teaching; Student Recruitment-Retention; Distance Learning Modalities; Research & funding; Community Health; Sustainable Entrepreneurship; Strategic Planning; Sociology; Disruptive Innovation; and Global Business Strategies.
New Drug Approvals 
Reblogged this on DRUG REGULATORY AFFAIRS INTERNATIONAL.
LikeLike